The Role of the Chemokine Receptor CXCR3 Axis in the Efficacy of Oncolytic Vesicular Stomatitis Virus Therapy in Combination with Natural Killer T Cell Activation Immunotherapy in Melanoma
The Role of the Chemokine Receptor CXCR3 Axis in the Efficacy of Oncolytic Vesicular Stomatitis Virus Therapy in Combination with Natural Killer T Cell Activation Immunotherapy in Melanoma
批准号:
449649
负责人:
Nickerson Rhea
金额:
$1.27万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-12-01 至 2021-12-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
One in forty-eight Canadians will develop melanoma in their lifetime, and the last two decades have seen a steady rise in melanoma cases. While surgery is highly effective in early melanoma, advanced melanoma is metastatic and resistant to traditional che
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金